Patriot Financial Group Insurance Agency, LLC Sage Therapeutics, Inc. Transaction History

Patriot Financial Group Insurance Agency, LLC

$720 Million
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$27.52 - $37.99 $908 - $1,253	-33 Reduced 19.19%	139 $4,000
Q1 2022 May 11, 2022	BUY	$30.71 - $45.71 $4,237 - $6,307	138 Added 405.88%	172 $6,000
Q4 2021 Jan 10, 2022	SELL	$37.06 - $47.11 $3,594 - $4,569	-97 Reduced 74.05%	34 $1,000
Q2 2021 Jul 30, 2021	BUY	$54.88 - $79.29 $2,634 - $3,805	48 Added 57.83%	131 $7,000
Q1 2021 Apr 29, 2021	SELL	$70.65 - $96.76 $282 - $387	-4 Reduced 4.6%	83 $6,000
Q1 2020 Apr 15, 2020	BUY	$26.15 - $77.24 $2,275 - $6,719	87 New	87 $2,000

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Account